Navigation Links
ConforMIS Moves Headquarters to Expanded Facilities in Burlington, MA
Date:8/30/2007

BURLINGTON, Mass., Aug. 30 /PRNewswire/ -- ConforMIS, a privately held medical device company dedicated to developing and marketing patient-specific orthopedic implants, today announced completion of its move to a new 15,000-sq.-foot headquarter facility in Burlington, MA.

The new facility was chosen to accommodate ConforMIS' rapid growth and marks the completion of the management team's efforts to move commercial operations to Massachusetts. The Burlington headquarter office combines operational functions that previously resided in Foster City, CA and Lexington, MA, including customer service, imaging services, and implant design. The facility will also allow ConforMIS to bring additional capabilities online in one location, such as manufacturing, rapid prototyping, product sterilization, packaging and shipping, and implant engineering and development.

"Our new headquarters will allow us to scale our operations to better support the rapid growth we have experienced over the last year and expect to see over the foreseeable future," said Patrick Hess, CEO of ConforMIS. "Not only will it accommodate the ongoing expansion of key company functions, it also gives us the ability to bring in new infrastructure that was not possible at our previous facilities."

The new offices are located at 2 Fourth Avenue, Burlington, MA 01803. The company's telephone numbers, including those for Imaging Services and Customer Service, remain the same.

About ConforMIS, Inc.

ConforMIS is a privately held medical device company whose mission is to provide best-in-class, minimally invasive implants for orthopedics and sports medicine through the use of its proprietary iFit Technology(TM). The iFit Technology is a patent-protected, software-enabled process for converting CT and MR imaging data into personalized, patient-specific implants. This "image-to-implant" technology allows for precisely sized and shaped implants that reduce or eliminate the need for cartilage or bone resection and radically simplify the surgical procedure. To date, the company has applied this technology to the knee joint and developed a comprehensive line of knee implants for all stages of osteoarthritis. For more information please visit http://www.conformis.com.

Contact:

Patrick Hess, CEO

(650) 286-4151 ext. 1102

Jong Lee, SVP Marketing

(781) 860-5111 ext. 1107

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE ConforMIS, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Wisconsin spaceport committee moves closer to formation
2. Sonic Foundrys Mediasite moves to podcasts
3. Blogging moves to corporate America
4. A budget that moves Wisconsin forward
5. Merge eFilm corporate merger with Canadian firm moves ahead
6. Star panel re-evaluates Sarbanes-Oxley one year in at SEC headquarters
7. Rayovac to Relocate Headquarters
8. RedPrairie Establishes Asia-Pacific Headquarters in Shanghai
9. Data centers: Buyers beware of over-hyped facilities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... , Jan 19, 2017 Research and Markets ... Profiling Technology, Biomolecules, Cancer Type, Application - Global Opportunity Analysis and ... ... that the global market is projected to reach $15,737 million by ... from 2016 to 2022. Omic technologies segment accounted ...
(Date:1/19/2017)... 2017 /PRNewswire -- WuXi AppTec, a leading global ... technology platform, today announced that it has acquired ... drug discovery contract research organization (CRO). After completion ... subsidiary of WuXi, and will continue to focus ... services. The acquisition will further strengthen WuXi,s R&D ...
(Date:1/19/2017)... ... January 19, 2017 , ... November Research Group, LLC, a ... medical device manufacturers and regulators, is proud to announce the worldwide release of ... designed to provide product vigilance departments with the flexibility and ease of use ...
(Date:1/19/2017)... 2017 AquaBounty Technologies, Inc. (AIM: ABTU; NASDAQ: ... aquaculture and a majority-owned subsidiary of Intrexon Corporation (NYSE: ... the listing of its common shares on the NASDAQ ... "AquaBounty,s listing on NASDAQ represents an important ... to the U.S. markets as we advance plans for ...
Breaking Biology Technology:
(Date:1/4/2017)... VEGAS , Jan. 4, 2017  For the thousands of attendees ... a global leader in connected health and biometric measurement devices and services, ... monitors. On display in A&D Medical,s special CES Exhibit ... represent the ongoing expansion of the company,s WellnessConnected product platform.  ... ...
(Date:12/22/2016)... 2016  As part of its longstanding mission to improve ... company, recently released its latest children,s book, titled ... on the topics of inheritance and variation of traits that ... in elementary school classrooms in the US. ... Ariana Killoran , whose previous book with 23andMe, ...
(Date:12/20/2016)... 20, 2016   Valencell , the leading ... STMicroelectronics (NYSE: STM), a global semiconductor leader ... announced today the launch of a new, highly ... that includes ST,s compact SensorTile turnkey ... biometric sensor system. Together, SensorTile and Benchmark deliver ...
Breaking Biology News(10 mins):